{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:49:14Z","timestamp":1783680554746,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study investigated temporal trends in the treatment and mortality of patients with cardiogenic shock (CS) in Taiwan in relation to acute myocardial infarction (AMI) accreditation implemented in 2009 and the unavailability of percutaneous ventricular assist devices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data of patients diagnosed as having CS between January 2003 and December 2017 were collected from Taiwan\u2019s National Health Insurance Research Database. Each case was followed from the date of emergency department arrival or hospital admission for the first incident associated with a CS diagnosis up to a 1-year interval. Measurements included demographics, comorbidities, treatment, mortality, and medical costs. Using an interrupted time-series (ITS) design with multi-level mixed-effects logistic regression model, we assessed the impact of AMI accreditation implementation on the mortality of patients with AMI and CS overall and stratified by the hospital levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 64\u2009049 patients with CS (mean age:70\u00a0years; 62% men) were identified. The incidence rate per 10<jats:sup>5<\/jats:sup> person-years increased from 17 in 2003 to 25 in 2010 and plateaued thereafter. Average inpatient costs increased from 159 125 points in 2003 to 240 993 points in 2017, indicating a 1.5-fold increase. The intra-aortic balloon pump application rate was approximately 22\u201325% after 2010 (<jats:italic>p<\/jats:italic>\u2009=\u20090.093). Overall, in-hospital, 30-day, and 1-year mortality declined from 60.3%, 63.0%, and 69.3% in 2003 to 47.9%, 50.8% and 59.8% in 2017, respectively. The decline in mortality was more apparent in patients with AMI-CS than in patients with non-AMI-CS. The ITS estimation revealed a 2% lower in-hospital mortality in patients with AMI-CS treated in district hospitals after the AMI accreditation had been implemented for 2\u00a0years.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In Taiwan, the burden of CS has consistently increased due to high patient complexity, advanced therapies, and stable incidence. Mortality declined over time, particularly in patients with AMI-CS, which may be attributable to advancements in AMI therapies and this quality-improving policy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-021-03820-1","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:03:12Z","timestamp":1637236992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cardiogenic shock in Taiwan from 2003 to 2017 (CSiT-15 study)"],"prefix":"10.1186","volume":"25","author":[{"given":"Shih-Chieh","family":"Chien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Lieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Nien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"issue":"16","key":"3820_CR1","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136(16):e232\u201368.","journal-title":"Circulation"},{"issue":"32","key":"3820_CR2","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","volume":"40","author":"H Thiele","year":"2019","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40(32):2671\u201383.","journal-title":"Eur Heart J"},{"issue":"4","key":"3820_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jama.294.4.448","volume":"294","author":"A Babaev","year":"2005","unstructured":"Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294(4):448\u201354.","journal-title":"JAMA"},{"issue":"6","key":"3820_CR4","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00134-018-5214-9","volume":"44","author":"A Mebazaa","year":"2018","unstructured":"Mebazaa A, Combes A, van Diepen S, Hollinger A, Katz JN, Landoni G, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;44(6):760\u201373.","journal-title":"Intensive Care Med"},{"issue":"4","key":"3820_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","volume":"107","author":"M Shah","year":"2018","unstructured":"Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018;107(4):287\u2013303.","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"3820_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jchf.2020.09.005","volume":"8","author":"BN Tehrani","year":"2020","unstructured":"Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and comprehensive approach to the management of cardiogenic shock. JACC Heart Fail. 2020;8(11):879\u201391.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"3820_CR7","doi-asserted-by":"publisher","first-page":"e000590","DOI":"10.1161\/JAHA.113.000590","volume":"3","author":"D Kolte","year":"2014","unstructured":"Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, et al. Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc. 2014;3(1):e000590.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3820_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jcin.2015.10.039","volume":"9","author":"SA Wayangankar","year":"2016","unstructured":"Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI registry. JACC Cardiovasc Inter. 2016;9(4):341\u201351.","journal-title":"JACC Cardiovasc Inter"},{"issue":"5","key":"3820_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"VP Harjola","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, K\u00f8ber L, Tarvasm\u00e4ki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"3820_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7326\/0003-4819-149-9-200811040-00005","volume":"149","author":"RV Jeger","year":"2008","unstructured":"Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, et al. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149(9):618\u201326.","journal-title":"Ann Intern Med"},{"issue":"9","key":"3820_CR11","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","volume":"175","author":"AW Hsing","year":"2015","unstructured":"Hsing AW, Ioannidis JP. Nationwide population science: lessons from the Taiwan National Health Insurance research database. JAMA Intern Med. 2015;175(9):1527\u20139.","journal-title":"JAMA Intern Med"},{"key":"3820_CR12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, et al. Taiwan\u2019s National Health Insurance Research database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"3820_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12874-019-0777-x","volume":"19","author":"J Hudson","year":"2019","unstructured":"Hudson J, Fielding S, Ramsay CR. Methodology and reporting characteristics of studies using interrupted time series design in healthcare. BMC Med Res Methodol. 2019;19(1):137.","journal-title":"BMC Med Res Methodol"},{"issue":"5","key":"3820_CR14","first-page":"416","volume":"36","author":"T Ko","year":"2020","unstructured":"Ko T, Yang CH, Mao CT, Kuo LT, Hsieh MJ, Chen DY, et al. Effects of national hospital accreditation in acute coronary syndrome on In-hospital mortality and clinical outcomes. Acta Cardiol Sin. 2020;36(5):416\u201327.","journal-title":"Acta Cardiol Sin"},{"key":"3820_CR15","unstructured":"Ministry of Health and Welfare ROC. Taiwan Health and Welfare Report (2010\u20132017). https:\/\/www.mohw.gov.tw\/lp-137-2.html."},{"issue":"20","key":"3820_CR16","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/sim.7336","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med. 2017;36(20):3257\u201377.","journal-title":"Stat Med"},{"issue":"3","key":"3820_CR17","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ije\/dyu029","volume":"43","author":"CJ Muller","year":"2014","unstructured":"Muller CJ, MacLehose RF. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. Int J Epidemiol. 2014;43(3):962\u201370.","journal-title":"Int J Epidemiol"},{"issue":"11","key":"3820_CR18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1097\/01.CCM.0000146301.47334.BD","volume":"32","author":"LM Cooper","year":"2004","unstructured":"Cooper LM, Linde-Zwirble WT. Medicare intensive care unit use: analysis of incidence, cost, and payment. Crit care med. 2004;32(11):2247\u201353.","journal-title":"Crit care med"},{"issue":"8","key":"3820_CR19","doi-asserted-by":"publisher","first-page":"e011322","DOI":"10.1161\/JAHA.118.011322","volume":"8","author":"PA Cowper","year":"2019","unstructured":"Cowper PA, Knight JD, Davidson-Ray L, Peterson ED, Wang TY, Mark DB. Acute and 1-year hospitalization costs for acute myocardial infarction treated with percutaneous coronary intervention: results\u00a0from the TRANSLATE-ACS registry. J Am Heart Assoc. 2019;8(8):e011322.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3820_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00392-017-1192-0","volume":"107","author":"T Backhaus","year":"2018","unstructured":"Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, et al. Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clin Res Cardiol. 2018;107(5):371\u20139.","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"3820_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779\u201389.","journal-title":"N Engl J Med"},{"issue":"2","key":"3820_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","volume":"72","author":"B Levy","year":"2018","unstructured":"Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72(2):173\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"3820_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1001\/jama.2010.1190","volume":"304","author":"D Perera","year":"2010","unstructured":"Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010;304(8):867\u201374.","journal-title":"JAMA"},{"issue":"1","key":"3820_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/2048872617711169","volume":"7","author":"N Br\u00e9chot","year":"2018","unstructured":"Br\u00e9chot N, Demondion P, Santi F, Lebreton G, Pham T, Dalakidis A, et al. Intra-aortic balloon pump protects against hydrostatic pulmonary oedema during peripheral venoarterial-extracorporeal membrane oxygenation. Eur Heart J Acute Cardiovasc Care. 2018;7(1):62\u20139.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"3820_CR25","first-page":"Cd007398","volume":"3","author":"S Unverzagt","year":"2015","unstructured":"Unverzagt S, Buerke M, de Waha A, Haerting J, Pietzner D, Seyfarth M, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2015;3:Cd007398.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"3820_CR26","first-page":"172","volume":"15","author":"A Zangrillo","year":"2013","unstructured":"Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G, et al. A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013;15(3):172\u20138.","journal-title":"Crit Care Resusc"},{"issue":"4","key":"3820_CR27","first-page":"326","volume":"36","author":"SC Chien","year":"2020","unstructured":"Chien SC, Lan WR, Wu SH, Chien CY, Chien YS, Lo CI, et al. Application and comparison of different prognostic scoring systems in patients who underwent cardiologist-managed percutaneous cardiopulmonary support. Acta Cardiol Sin. 2020;36(4):326\u201334.","journal-title":"Acta Cardiol Sin"},{"issue":"9","key":"3820_CR28","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/CCM.0000000000003879","volume":"47","author":"SP Keller","year":"2019","unstructured":"Keller SP. Management of peripheral venoarterial extracorporeal membrane oxygenation in cardiogenic shock. Crit Care Med. 2019;47(9):1235\u201342.","journal-title":"Crit Care Med"},{"issue":"1","key":"3820_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13054-019-2368-y","volume":"23","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Teboul JL. Mechanical circulatory support devices for cardiogenic shock: state of the art. Crit Care (Lond, Engl). 2019;23(1):76.","journal-title":"Crit Care (Lond, Engl)"},{"issue":"4","key":"3820_CR30","doi-asserted-by":"publisher","first-page":"e007293","DOI":"10.1161\/CIRCINTERVENTIONS.118.007293","volume":"12","author":"L Hunziker","year":"2019","unstructured":"Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, et al. Twenty-year trends in the incidence and outcome of cardiogenic shock in AMIS plus registry. Circ Cardiovasc Interv. 2019;12(4):e007293.","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"3820_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1253\/circj.CJ-16-0125","volume":"80","author":"Y Ueki","year":"2016","unstructured":"Ueki Y, Mohri M, Matoba T, Tsujita Y, Yamasaki M, Tachibana E, et al. Characteristics and predictors of mortality in patients with cardiovascular shock in Japan- results from the Japanese circulation society cardiovascular shock registry. Circ J. 2016;80(4):852\u20139.","journal-title":"Circ J"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-021-03820-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-021-03820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:11:50Z","timestamp":1637237510000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-021-03820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1186\/s13054-021-03820-1","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]},"assertion":[{"value":"11 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved with a waiver of informed consent by the Joint Institutional Review Board of Taipei Medical University (N202012062).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"402"}}